Enhancement of antitumor activity of docetaxel by celecoxib in lung tumors. - Wikidata - wikimedia - TriplyDB

Enhancement of antitumor activity of docetaxel by celecoxib in lung tumors.

Enhancement of antitumor activity of docetaxel by celecoxib in lung tumors.

http://www.wikidata.org/entity/Q34008146

about

Enhancement of docetaxel anticancer activity by a novel diindolylmethane compound in human non-small cell lung cancer Inhalation delivery and anti-tumor activity of celecoxib in human orthotopic non-small cell lung cancer xenograft model Inhalation delivery of a novel diindolylmethane derivative for the treatment of lung cancer Dioscorea japonica extract down-regulates prostaglandin E2 synthetic pathway and induces apoptosis in lung cancer cells.The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR).Induction but not inhibition of COX-2 confers human lung cancer cell apoptosis by celecoxib.Anti-Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions Efficacy of aerosolized celecoxib encapsulated nanostructured lipid carrier in non-small cell lung cancer in combination with docetaxel.NSAIDs induce apoptosis in nonproliferating ovarian cancer cells and inhibit tumor growth in vivo.Inhibitory effect of celecoxib in lung carcinoma by regulation of cyclooxygenase-2/cytosolic phospholipase A₂ and peroxisome proliferator-activated receptor gamma.Phenylbutyrate induces apoptosis and lipid accumulations via a peroxisome proliferator-activated receptor gamma-dependent pathway.Molecular pathways involved in the synergistic interaction of the PKC beta inhibitor enzastaurin with the antifolate pemetrexed in non-small cell lung cancer cells.Anti-cancer effect of celecoxib and aerosolized docetaxel against human non-small cell lung cancer cell line, A549.Combination Therapy of PPARgamma Ligands and Inhibitors of Arachidonic Acid in Lung Cancer Lymphoblastic T-cell lymphoma in mice is unaffected by Celecoxib as single agent or in combination with cyclophosphamide.

P2860

Q33837550-F2313A70-7EB4-4977-BF72-8D6869318AD5 Q33987004-FFA6E0B2-12AF-46BC-8BE9-0CEE52B7AE0E Q34300257-0BBF860D-8181-492C-A7F1-162856D1C1E6 Q34489929-15627E17-C1DC-40C7-812C-4C1E61F5F577 Q36328530-2421ECC8-65A3-4965-A1B1-457A8E3353F2 Q37222698-F560F57D-542A-40BB-83A3-5027E50A4EB1 Q37226245-9D8F350B-CACC-41E8-8154-D0298713CB09 Q39202347-ECFA4326-F21F-4F06-AF2C-42FE7E58B354 Q39350226-6EB9176B-6CD8-451E-828E-28021FF10D3A Q39544858-D1B3561A-CD51-4C1A-9C22-66708A929838 Q39728530-ACD7F189-C43B-4E06-B8EB-2683AD02A907 Q39946933-00E1AA87-DF5F-4C2E-80BC-D3CBF9255DC2 Q40305196-6C78661A-3CB3-4D8C-A260-BA4BECF1A33A Q42126506-C95B8215-773C-4AA2-8DB0-04979C255394 Q45951584-28354283-45C5-42E9-A1D7-133FF27D998E

P2860

Enhancement of antitumor activity of docetaxel by celecoxib in lung tumors.

http://www.wikidata.org/entity/Q34008146

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Enhancement of antitumor activity of docetaxel by celecoxib in lung tumors.

@ast

Enhancement of antitumor activity of docetaxel by celecoxib in lung tumors.

@en

Enhancement of antitumor activity of docetaxel by celecoxib in lung tumors.

@nl

type

label

Enhancement of antitumor activity of docetaxel by celecoxib in lung tumors.

@ast

Enhancement of antitumor activity of docetaxel by celecoxib in lung tumors.

@en

Enhancement of antitumor activity of docetaxel by celecoxib in lung tumors.

@nl

prefLabel

Enhancement of antitumor activity of docetaxel by celecoxib in lung tumors.

@ast

Enhancement of antitumor activity of docetaxel by celecoxib in lung tumors.

@en

Enhancement of antitumor activity of docetaxel by celecoxib in lung tumors.

@nl

P1433

Q34008146-14C5EA52-2C89-4FF1-81D7-7FDDE2DDA8DA

P1476

Q34008146-9E879778-9C61-49E7-9F63-23131096EBAF

P2093

Q34008146-2812142C-3D4E-4ABF-8E60-DBED4DD466A3

Q34008146-873A91F1-BF3C-4626-976D-5E63E37F657D

Q34008146-A283DB1E-4F62-4E88-83CD-15553D461075

Q34008146-B4192E85-9D30-4050-9020-73D2CB056523

P2860

Q34008146-10149A60-E3D5-48E8-AD2B-9DE1583A3D2C

Q34008146-10B69E03-E2D8-4CF6-A77B-591056A144CF

Q34008146-17A3C225-82D9-4A3B-A171-5103B0C2B28D

Q34008146-21012D5A-F3B2-4B63-8015-8318A0CA1113

Q34008146-2221604B-4FE1-4D3A-89BC-7E3E5C04B300

Q34008146-2D5FDAAF-B27B-4485-9A6F-73A1364D038A

Q34008146-2F37A9ED-C786-4134-9D66-8AE56F29490E

Q34008146-3308C5EB-4A89-4363-AC4A-47DFF69ADFBB

Q34008146-42D465A4-EC17-45B6-BD19-284BC003A3EE

Q34008146-44745F6E-F35E-4174-BFA6-D6D6D6B8B8F6

P304

Q34008146-B60E7BDF-C438-4715-9083-6DC497AB9A44

P31

Q34008146-A2D715AA-B1D1-416C-AD8D-8521870D745C

P356

Q34008146-68F24FD8-9A61-4791-B753-6D98DA2BB5DE

P433

Q34008146-1E4F3063-F2F7-4F00-A469-F3CE111FBE01

P478

Q34008146-7AD47A52-26B0-4923-9DC9-70EEABC92F9B

P577

Q34008146-4EF2D4F0-E95B-485B-90C1-86313FB1E7B8

P5875

Q34008146-0FBEDE40-DF43-4239-BFAE-377A402F4CA2

P698

Q34008146-A888E926-7132-4CAB-8ADB-E4C8D1CCE58C

P932

Q34008146-C84BA5EB-EA1D-4222-8B94-3E2D2623C4E1

P356

P1433

International Journal of Cancer

P1476

Enhancement of antitumor activity of docetaxel by celecoxib in lung tumors.

@en

P2093

Abhijit Chatterjee

http://www.w3.org/2001/XMLSchema#string

Madhu Sudhan Shaik

http://www.w3.org/2001/XMLSchema#string

Mandip Singh

http://www.w3.org/2001/XMLSchema#string

Tanise Jackson

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of cytosolic phospholipase A2 mRNA expression: a novel mechanism for acetylsalicylic acid-mediated growth inhibition and apoptosis in colon cancer cells

Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis

Formulation and evaluation of aerosolized celecoxib for the treatment of lung cancer.

Exisulind-induced apoptosis in a non-small cell lung cancer orthotopic lung tumor model augments docetaxel treatment and contributes to increased survival.

Inhibition of cyclooxygenase-2: an approach to preventing cancer of the upper aerodigestive tract.

Signal transduction pathways of taxanes-induced apoptosis.

Expression of cyclooxygenase-2 in human lung carcinoma.

Selective cyclooxygenase-2 inhibition: a target in cancer prevention and treatment.

Cyclooxygenase-2 interacts with p53 and interferes with p53-dependent transcription and apoptosis.

Effect of a selective cyclooxygenase-2 inhibitor, nimesulide, on the growth of lung tumors and their expression of cyclooxygenase-2 and peroxisome proliferator- activated receptor-gamma.

P304

396-404

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.21325

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7692336

http://www.w3.org/2001/XMLSchema#string

P698

16052515

http://www.w3.org/2001/XMLSchema#string

P932

2907249

http://www.w3.org/2001/XMLSchema#string